The Europe Bariatric Surgery Devices Market would witness market growth of 4.8% CAGR during the forecast period (2022-2028).
The metabolic and bariatric procedures used today have been improved over many years and are some of the most well-researched medical procedures available. With the use of minimally invasive surgical methods, they are carried out through tiny incisions (robotic and laparoscopic surgery). These developments make it possible for patients to experience a better overall outcome with less discomfort, fewer complications, reduced hospital stay duration, and a quicker recovery. These procedures are much less likely to cause complications than popular procedures, like hysterectomy, gallbladder removal, and hip replacement.
These procedures aim to alter the stomach and intestines in order to address obesity and associated disorders. The procedures could reduce the size of the stomach and potentially skip a section of the intestine. This reduces the amount of food consumed and alters how the body uses food for energy, which increases feelings of fullness and decreases appetite.
The medical equipment and devices sector in regional countries is very significant and offers various considerable growth prospects to the market players operating in the region. Germany is one of the largest markets of medical devices and equipment in the region. According to the International Trade Administration, Germany has the third-biggest medical technology market in the world. It is also the largest industry in Europe, with a market size, which is double of France as well as three times that of the United Kingdom, Italy, and Spain. The German medical device market, which accounts for about USD 35.8 billion annually or 25.6% of the entire European market, is one of the most profitable healthcare markets in the world.
The Germany market dominated the Europe Bariatric Surgery Devices Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $160.4 million by 2028. The UK market is registering a CAGR of 3.9% during (2022 - 2028). Additionally, The France market would showcase a CAGR of 5.6% during (2022 - 2028).
Based on Devices Type, the market is segmented into Minimally Invasive Surgical Devices and Noninvasive Surgical Devices. Based on Minimally Invasive Surgical Devices Type, the market is segmented into Accessories, Suturing Devices, Stapling Devices and Energy/Vessel-sealing Devices. Based on Procedure, the market is segmented into Sleeve Gastrectomy, Noninvasive Bariatric Surgery, Adjustable Gastric Banding, Gastric Bypass, Revision Bariatric Surgery, Mini-gastric Bypass and Biliopancreatic Diversion with Duodenal Switch (BPD/DS). Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Bariatric Surgery Devices Market will Hit $2.4 Billion by 2028, at a CAGR of 5.3%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Johnson & Johnson, ReShape Lifesciences, Inc., Apollo Endosurgery, Inc., Medtronic PLC, Olympus Corporation, Intuitive Surgical, Inc., B. Braun Melsungen AG, Spatz FGIA, Inc., Cook Medical, Inc. (Cook Group), and Richard Wolf GmbH.
By Devices Type
By Procedure
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
